Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 20144857)

1.

Immunity to stemness genes in human cancer.

Dhodapkar MV.

Curr Opin Immunol. 2010 Apr;22(2):245-50. doi: 10.1016/j.coi.2010.01.011. Epub 2010 Feb 9. Review.

2.

Vaccines targeting cancer stem cells: are they within reach?

Dhodapkar MV, Dhodapkar KM.

Cancer J. 2011 Sep-Oct;17(5):397-402. doi: 10.1097/PPO.0b013e318233e730. Review.

3.

Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.

Dhodapkar MV, Dhodapkar KM.

Cancer Immunol Immunother. 2011 Mar;60(3):413-8. doi: 10.1007/s00262-010-0944-8. Epub 2010 Nov 23. Review.

4.

Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.

Hirohashi Y, Torigoe T, Inoda S, Takahashi A, Morita R, Nishizawa S, Tamura Y, Suzuki H, Toyota M, Sato N.

Immunotherapy. 2010 Mar;2(2):201-11. doi: 10.2217/imt.10.10. Review.

PMID:
20635928
5.

Understanding and activating immunity against human cancer.

Stevenson FK, Palucka K.

Curr Opin Immunol. 2010 Apr;22(2):212-4. doi: 10.1016/j.coi.2010.03.001. Epub 2010 Mar 24. No abstract available.

6.

Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors.

Sabbatino F, Wang Y, Wang X, Schwab JH, Ferrone S, Ferrone CR.

Semin Oncol. 2014 Oct;41(5):685-99. doi: 10.1053/j.seminoncol.2014.08.007. Epub 2014 Aug 12. Review.

PMID:
25440613
7.

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

Dunning NL, Laversin SA, Miles AK, Rees RC.

Cancer Immunol Immunother. 2011 Aug;60(8):1181-93. doi: 10.1007/s00262-011-1065-8. Epub 2011 Jun 19. Review.

PMID:
21688178
8.

[Immunotherapy targeting cancer stem cells].

Kawakami Y, Matsushita M, Ueda R, Tsukamoto N, Ohta S.

Nihon Rinsho. 2012 Dec;70(12):2142-6. Review. Japanese.

PMID:
23259387
9.

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.

Stem Cells. 2009 Aug;27(8):1734-40. doi: 10.1002/stem.102.

10.

Therapeutic gene modified cell based cancer vaccines.

Kozłowska A, Mackiewicz J, Mackiewicz A.

Gene. 2013 Aug 10;525(2):200-7. doi: 10.1016/j.gene.2013.03.056. Epub 2013 Apr 6. Review.

PMID:
23566846
11.

Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.

Fukushima S, Hirata S, Motomura Y, Fukuma D, Matsunaga Y, Ikuta Y, Ikeda T, Kageshita T, Ihn H, Nishimura Y, Senju S.

J Immunother. 2009 Apr;32(3):219-31. doi: 10.1097/CJI.0b013e318194b63b.

PMID:
19242378
12.

Immunology of cancer stem cells in solid tumours. A review.

Maccalli C, Volontè A, Cimminiello C, Parmiani G.

Eur J Cancer. 2014 Feb;50(3):649-55. doi: 10.1016/j.ejca.2013.11.014. Epub 2013 Dec 12. Review.

PMID:
24333096
13.

Immunotherapeutic potential of whole tumour cells.

Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S.

Cancer Immunol Immunother. 2002 Sep;51(7):351-7. Epub 2002 Jun 14. Review.

PMID:
12192534
14.

MicroRNAs in human embryonic and cancer stem cells.

Navarro A, Monzo M.

Yonsei Med J. 2010 Sep;51(5):622-32. doi: 10.3349/ymj.2010.51.5.622.

15.

Specificity in cancer immunotherapy.

Schietinger A, Philip M, Schreiber H.

Semin Immunol. 2008 Oct;20(5):276-85. doi: 10.1016/j.smim.2008.07.001. Epub 2008 Aug 5. Review.

16.

Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.

Mori T, Nishizawa S, Hirohashi Y, Torigoe T, Tamura Y, Takahashi A, Kochin V, Fujii R, Kondo T, Greene MI, Hara I, Sato N.

Exp Mol Pathol. 2012 Feb;92(1):27-32. doi: 10.1016/j.yexmp.2011.09.016. Epub 2011 Oct 2.

PMID:
22001602
17.

Cellular vaccine therapies for cancer.

Mastrangelo MJ, Sato T, Lattime EC, Maguire HC Jr, Berd D.

Cancer Treat Res. 1998;94:35-50. Review. No abstract available.

PMID:
9587681
18.

Cytotoxic T lymphocytes: the future of cancer stem cell eradication?

Saijo H, Hirohashi Y, Torigoe T, Kochin V, Takahashi H, Sato N.

Immunotherapy. 2013 Jun;5(6):549-51. doi: 10.2217/imt.13.44. No abstract available.

19.

Immune based therapies in cancer.

Krüger C, Greten TF, Korangy F.

Histol Histopathol. 2007 Jun;22(6):687-96. Review.

PMID:
17357098
20.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk